Abstract
This article presents an overview of the current literature on PET imaging with prostate-specific membrane antigen ligands, especially focusing on the potential role of simultaneous PET/magnetic resonance imaging for the planning of salvage radiotherapy in patients with prostate cancer with biochemical recurrence after radical prostatectomy.
Keywords:
MR imaging; PET; PSMA; Prostate cancer; Prostatectomy; Recurrence; Salvage radiotherapy.
Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.
MeSH terms
-
Aged
-
Biomarkers, Tumor / blood
-
Humans
-
Magnetic Resonance Imaging / methods
-
Male
-
Middle Aged
-
Multimodal Imaging / methods*
-
Neoplasm Invasiveness / pathology
-
Neoplasm Recurrence, Local / diagnostic imaging*
-
Neoplasm Recurrence, Local / radiotherapy
-
Neoplasm Staging
-
Positron-Emission Tomography / methods
-
Prognosis
-
Prostate-Specific Antigen / blood*
-
Prostatectomy / methods
-
Prostatic Neoplasms / diagnostic imaging*
-
Prostatic Neoplasms / mortality
-
Prostatic Neoplasms / radiotherapy*
-
Prostatic Neoplasms / surgery
-
Radiosurgery
-
Radiotherapy Planning, Computer-Assisted / methods*
-
Risk Assessment
-
Salvage Therapy / methods
-
Survival Analysis
-
Treatment Outcome
Substances
-
Biomarkers, Tumor
-
Prostate-Specific Antigen